Expanding Product Portfolio in Transplant Diagnostics

Investor News

Paragon Care has recently expanded its product portfolio in Diagnostics through a new supply contract for transplant products. This new product offering will contribute to the underlying growth in the Diagnostics division over the years ahead.

Immulab is a leading manufacturer and provider of blood banking reagents and solutions in Australia and the Immulab business sits within Paragon Care’s Diagnostics pillar. Immulab is the only Australian owned manufacturer of In Vitro Diagnostics (IVDs) for Blood Banks.

Immucor is a leading provider of transfusion and transplantation diagnostics products globally and is dedicated to matching donors with patients in need of blood or an organ.

In 2014, Immulab was appointed the exclusive distributor for Immucor Transfusion Diagnostics in Australia and New Zealand. Since that time, Immulab has grown the Immucor transfusion business significantly. In fact, since 2016 blood donations in Australia have been screened using Immucor automation and reagents – that is over 1 million donations each year!

Immulab has now expanded its exclusive distribution relationship with Immucor in Australia and New Zealand to include Transplant Diagnostic products, commencing in early 2021. The transfusion and transplant diagnostic product ranges are highly complementary as they are utilised to ensure the right match for patients in need of blood or an organ.

Immucor’s transplant diagnostics division develops, manufactures and sells a complete line of assays to perform pre-transplant typing and screening and post-transplant monitoring. In Australia, there are over 1,700 people waiting for their life-saving second chance, a transplant. With the right match, the transplant can transform a life.

The extension of this distribution relationship validates Paragon Care’s market leading position as a distributor of choice for global manufacturers who want to expand in the Australian and New Zealand market.